The Clorox Company (CLX) has been named as one of the
best household stocks to buy by hedge funds, with a high institutional backing of 81-83%. Clorox has been recovering from a cyberattack and continues to maintain a dividend tradition with a regular quarterly dividend of $1.22 per share. Analysts such as Jefferies have adjusted their price target on Clorox to $182 from $189, while retaining a
'Buy' rating. The company also successfully beat Q2 and Q1 earnings and sales estimates, updating the FY25 outlook, however, the stock fell by 7.2% post Q2 earnings. The company also announced partnership with M2030 for climate action in their supply chain and earned the title of
2024 Safer Choice Partner of the Year from EPA. Clorox recently elected Stephen Bratspies and Pierre Breber to its board of directors and boosted sales through increased ad spending. Nevertheless, its overpricing versus other consumer staple stocks led to a rating downgrade. Other strategic highlights include the divestiture of its Better Health VMS Business and a $500M digital transformation.
Clorox Company CLX News Analytics from Wed, 01 May 2024 07:00:00 GMT to Sat, 29 Mar 2025 21:29:55 GMT -
Rating 7
- Innovation 3
- Information 8
- Rumor 6
